Clinical Trial

PULmonary Stimulation for Asthma Relief

Study acronym: PULSAR
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to assess the safety and efficacy of Pulmonary Neuromodulation in patients suffering from moderate to severe asthma
Trial Details
NCT Number NCT07709754
Lead Sponsor Spiro Medical, Inc.
Conditions Moderate to Severe Asthma
Enrollment 30 participants
Start Date 2026-08-01
Primary Completion 2027-01 (estimated)
Study Completion 2027-06 (estimated)
Updated on ClinicalTrials.gov 2026-07-17